- Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Gossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International Conference
- Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update
- Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other Indications
- Gossamer Bio Announces Publication of TORREY Phase 2 Results in the Lancet Respiratory Medicine
More ▼
Key statistics
On Wednesday, Gossamer Bio Inc (GOSS:NSQ) closed at 1.03, 127.62% above the 52 week low of 0.4525 set on Oct 24, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.99 |
---|---|
High | 1.03 |
Low | 0.9144 |
Bid | 0.99 |
Offer | 1.00 |
Previous close | 0.9598 |
Average volume | 4.50m |
---|---|
Shares outstanding | 226.22m |
Free float | 219.54m |
P/E (TTM) | -- |
Market cap | 217.12m USD |
EPS (TTM) | -1.05 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 18:00 BST.
More ▼